The potential role of sirtuins regarding the effects of exercise on aging-related diseases

Current Aging Science

Volumn 6, Issue 2, 2013, Pages 178-188

  Suwa, Masataka ^a   Sakuma, Kunihiro ^b  

^a TOHOKU INSTITUTE OF TECHNOLOGY   (Japan)

^b TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

AMP activated protein kinase; Dementia; Exercise; Infarction; Metabolic disease; Physical activity; Sirtuin; Stroke

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMOYL PHOSPHATE SYNTHASE; EARLY GROWTH RESPONSE FACTOR 1; FORKHEAD TRANSCRIPTION FACTOR; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1;

ADAPTATION; ADIPOSE TISSUE; AGING; ATHEROSCLEROSIS; BRAIN; BRAIN STEM; CAENORHABDITIS ELEGANS; CELL CYCLE PROGRESSION; CEREBELLUM; CEREBROVASCULAR ACCIDENT; DEMENTIA; DNA REPAIR; DROSOPHILA MELANOGASTER; ENDOTHELIUM CELL; ENDURANCE TRAINING; EXERCISE; FRONTAL LOBE; GASTROCNEMIUS MUSCLE; HEART; HEART LEFT VENTRICLE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INSULIN SENSITIVITY; LIPID OXIDATION; LIVER; MESENCEPHALON; METABOLIC DISORDER; MUSCLE; NONHUMAN; OXIDATIVE STRESS; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SACCHAROMYCES CEREVISIAE; SKELETAL MUSCLE; SOLEUS MUSCLE; TRICEPS BRACHII MUSCLE; ACETYLATION; ALZHEIMER DISEASE; APOPTOSIS; BINDING SITE; BIOGENESIS; BODY GROWTH; CARDIOVASCULAR RISK; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; COGNITION; DEACETYLATION; DIET RESTRICTION; ENERGY EXPENDITURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FAST MUSCLE; FATTY ACID OXIDATION; GENE EXPRESSION; GENOMIC INSTABILITY; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEAT STRESS; INSULIN RELEASE; LIPOGENESIS; LONGEVITY; METABOLISM; NERVE CELL PLASTICITY; PHYSICAL ACTIVITY; PROMOTER REGION; PROTEIN EXPRESSION; STRESS; THERMOGENESIS; UPREGULATION; UREA CYCLE;

EID: 84882740328     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/18746098112059990035     Document Type: Review

References (169)

1. Leitzmann MF, Park Y, Blair A, et al. Physical activity recommendations and decreased risk of mortality. Arch Intern Med 2007; 167(22): 2453-2460.
2. Arrieta A, Russell LB. Effects of leisure and non-leisure physical activity on mortality in U.S. adults over two decades. Ann Epidemiol 2008; 18(12): 889-895.
3. Schnohr P, Scharling H, Jensen JS. Changes in leisure-time physical activity and risk of death: an observational study of 7,000 men and women. Am J Epidemiol 2003; 158(7): 639-644.
4. Inoue M, Iso H, Yamamoto S, et al. Daily total physical activity level and premature death in men and women: results from a largescale population-based cohort study in Japan (JPHC study). Ann Epidemiol 2008; 18(7): 522-530.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403.
6. Hu FB, Sigal RJ, Rich-Edwards JW, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999; 282(15): 1433-1439.
7. Okada K, Hayashi T, Tsumura K, Suematsu C, Endo G, Fujii S. Leisure-time physical activity at weekends and the risk of Type 2 diabetes mellitus in Japanese men: the Osaka Health Survey. Diabet Med 2000; 17(1): 53-58.
8. Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002; 25(9): 1612-1618.
9. Ekelund U, Brage S, Franks PW, Hennings S, Emms S, Wareham NJ. Physical activity energy expenditure predicts progression toward the metabolic syndrome independently of aerobic fitness in middle-aged healthy Caucasians: the Medical Research Council Ely Study. Diabetes Care 2005; 28(5): 1195-200.
10. Wannamethee SG, Shaper AG, Whincup PH. Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes. J Am Geriatr Soc 2006; 54(12): 1909-1914.
11. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005; 28(4): 799-805.
12. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002; 347(10): 716-725.
13. Manson JE, Hu FB, Rich-Edwards JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341(9): 650-658.
14. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA 2000; 283(22): 2961-1967.
15. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58(3): 498-504.
16. Lautenschlager NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300(9): 1027-1037.
17. Escalante Y, Saavedra JM. Physical activity, exercise and aging. Curr Aging Sci 2012; 5(1):1.
18. Blake H, Hawley H. Effects of Tai Chi exercise on physical and psychological health of older people. Curr Aging Sci 2012; 5(1): 19-27.
19. Bello O, Fernandez-Del-Olmo M. How does the treadmill affect gait in Parkinson's disease? Curr Aging Sci 2012; 5(1): 28-34.
20. Lee AH, Hirayama F. Physical activity and urinary incontinence in older adults: a community-based study. Curr Aging Sci 2012; 5(1): 35-40.
21. Orozco LJ, Buchleitner AM, Gimenez-Perez G, et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev 2008; (3): CD003054.
22. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004; 85(10): 1694-1704.
23. Padilla J, Simmons GH, Bender SB, Arce-Esquivel AA, Whyte JJ, Laughlin MH. Vascular effects of exercise: endothelial adaptations beyond active muscle beds. Physiology (Bethesda). 2011; 26(3): 132-145.
24. Stranahan AM, Zhou Y, Martin B, Maudsley S. Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents. Curr Med Chem 2009; 16(35): 4668-4678.
25. Ma Q. Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 2008; 24(4): 265-270.
26. Yan Z, Okutsu M, Akhtar YN, Lira VA. Regulation of exerciseinduced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol 2011; 110(1): 264-274.
27. Kenyon CJ. The genetics of ageing. Nature 2010; 464(7288): 504-512.
28. Narasimhan SD, Yen K, Tissenbaum HA. Converging pathways in lifespan regulation. Curr Biol 2009; 19(15): R657-R666.
29. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010; 5: 253-295.
30. Polito L, Kehoe PG, Forloni G, Albani D. The molecular genetics of sirtuins: association with human longevity and age-related diseases. Int J Mol Epidemiol Genet 2010; 1(3): 214-225.
31. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001; 410(6825): 227-230.
32. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999; 13(19): 2570-2580.
33. Wang Y, Tissenbaum HA. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech Ageing Dev 2006; 127(1): 48-56.
34. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000; 289(5487): 2126-21268.
35. Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA 2004; 101(45): 15998-16003.
36. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273(2): 793-798.
37. Moynihan KA, Grimm AA, Plueger MM, et al. Increased dosage of mammalian Sir2 in pancreatic αcells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2005; 2(2): 105-117.
38. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 2007; 282(9): 6823-6832.
39. Motta MC, Divecha N, Lemieux M, et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116(4): 551-563.
40. Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107(2): 149-159.
41. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-_Bdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23(12): 2369-2380.
42. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1αand SIRT1. Nature 2005; 434(7029): 113-118.
43. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007; 6(4): 307-319.
44. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 α. Cell 2006; 127(6): 1109-1122.
45. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1 α. EMBO J 2007; 26(7): 1913-1923.
46. Ghosh HS, Spencer JV, Ng B, McBurney MW, Robbins PD. Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor α B-mediated transcription. Biochem J 2007; 408(1): 105-111.
47. Yoshizaki T, Milne JC, Imamura T, et al. SIRT1 exerts antiinflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29(5): 1363-1374.
48. Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004; 305(5686): 1010-1013.
49. Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF- α B signaling. J Biol Chem 2005; 280(48): 40364-40374.
50. Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134(2): 329-340.
51. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCKSIRT1. Science 2009; 324(5927): 654-7.
52. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 2003; 23(9): 3173-3185.
53. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005; 16(10): 4623-4635.
54. Jing E, Gesta S, Kahn CR. 2007. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 2007; 6(2): 105-114.
55. Krishnan J, Danzer C, Simka T, et al. Dietary obesity-associated Hif1αactivation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev 2012; 26(3): 259-270.
56. Bellizzi D, Rose G, Cavalcante P, et al. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005; 85(2): 258-263.
57. Rose G, Dato S, Altomare K, et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 2003; 38(10): 1065-1070.
58. Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 2002; 158(4): 647-657.
59. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005; 280(14): 13560-13567.
60. Hirschey MD, Shimazu T, Goetzman E, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010; 464(7285): 121-125.
61. Kong X, Wang R, Xue Y, et al. Sirtuin 3, a new target of PGC-1 plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010; 5(7): e11707.
62. Haigis MC, Mostoslavsky R, Haigis KM, et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic αcells. Cell 2006; 126(5): 941-954.
63. Nasrin N, Wu X, Fortier E, et al. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 2010; 285(42): 31995-2002.
64. Nakagawa T, Lomb DJ, Haigis MC, Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009; 137(3): 560-570.
65. Du J, Zhou Y, Su X, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011; 334(6057): 806-809.
66. Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature, in press.
67. Schwer B, Schumacher B, Lombard DB, et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci USA 2010; 107(50): 21790-21794.
68. Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124(2): 315-329.
69. Zhong L, D'Urso A, Toiber D, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 2010; 140(2): 280-293.
70. Xiao C, Kim HS, Lahusen T, et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulinstimulated glucose uptake in mice. J Biol Chem 2010; 285(47): 36776-36784.
71. Kim HS, Xiao C, Wang RH, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab 2010; 12(3): 224-236.
72. Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 2006; 20(9): 1075-1080.
73. Vakhrusheva O, Smolka C, Gajawada P, et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008; 102(6): 703-710.
74. Ferrara N, Rinaldi B, Corbi G, et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 2008; 11(1): 139-150.
75. Gurd BJ, Yoshida Y, McFarlan JT, et al. Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2011; 301(1): R67-R75.
76. Koltai E, Szabo Z, Atalay M, et al. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev 2010; 131(1): 21-28.
77. Gurd BJ, Perry CG, Heigenhauser GJ, Spriet LL, Bonen A. Highintensity interval training increases SIRT1 activity in human skeletal muscle. Appl Physiol Nutr Metab 2010; 35(3): 350-357.
78. Suwa M, Nakano H, Radak Z, Kumagai S. Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor αcoactivator-1αprotein expressions in rat skeletal muscle. Metabolism 2008; 57(7): 986-998.
79. Li L, Mühlfeld C, Niemann B, et al. Mitochondrial biogenesis and PGC-1αdeacetylation by chronic treadmill exercise: differential response in cardiac and skeletal muscle. Basic Res Cardiol 2011; 106(6): 1221-1234.
80. Li L, Pan R, Li R, et al. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-αcoactivator-1α(PGC-1α) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes 2011; 60(1): 157-167.
81. Little JP, Safdar A, Wilkin GP, Tarnopolsky MA, Gibala MJ. A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol 2010; 588(Pt 6): 1011-1022.
82. Pauli JR, Ropelle ER, Cintra DE, et al. Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle. Mech Ageing Dev 2010; 131(5): 323-329.
83. Guerra B, Guadalupe-Grau A, Fuentes T, et al. SIRT1, AMPactivated protein kinase phosphorylation and downstream kinases in response to a single bout of sprint exercise: influence of glucose ingestion. Eur J Appl Physiol 2010; 109(4): 731-743.
84. Hokari F, Kawasaki E, Sakai A, Koshinaka K, Sakuma K, Kawanaka K. Muscle contractile activity regulates Sirt3 protein expression in rat skeletal muscles. J Appl Physiol 2010; 109(2): 332-340.
85. Radak Z, Bori Z, Koltai E, et al. Age-dependent changes in 8- oxoguanine-DNA glycosylase activity are modulated by adaptive responses to physical exercise in human skeletal muscle. Free Radic Biol Med 2011; 51(2): 417-423.
86. Dumke CL, Mark Davis J, Angela Murphy E, et al. Successive bouts of cycling stimulates genes associated with mitochondrial biogenesis. Eur J Appl Physiol 2009; 107(4): 419-427.
87. Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol 2011; 111(4): 1066-1071.
88. Ljubicic V, Khogali S, Renaud JM, Jasmin BJ. Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle. Am J Physiol Cell Physiol 2012; 302(1): C110-C121.
89. Wang L, Mascher H, Psilander N, Blomstrand E, Sahlin K. Resistance exercise enhances the molecular signaling of mitochondrial biogenesis induced by endurance exercise in human skeletal muscle. J Appl Physiol 2011; 111(5): 1335-1344.
90. Palacios OM, Carmona JJ, Michan S, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1 in skeletal muscle. Aging. 2009; 1(9): 771-783.
91. Huffman DM, Moellering DR, Grizzle WE, Stockard CR, Johnson MS, Nagy TR. Effect of exercise and calorie restriction on biomarkers of aging in mice. Am J Physiol Regul Integr Comp Physiol 2008; 294(5): R1618-R1627.
92. Gurd BJ, Holloway GP, Yoshida Y, Bonen A. In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism 2012; 61(5): 733-741.
93. Lanza IR, Short DK, Short KR, et al. Endurance exercise as a countermeasure for aging. Diabetes 2008; 57(11): 2933-2942.
94. Bayod S, Del Valle J, Canudas AM, et al. Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. J Appl Physiol 2011; 111(5): 1380-1390.
95. Marton O, Koltai E, Nyakas C, et al. Aging and exercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats. Biogerontology 2010; 11(6): 679-686.
96. Cacicedo JM, Gauthier MS, Lebrasseur NK, Jasuja R, Ruderman NB, Ido Y. Acute exercise activates AMPK and eNOS in the mouse aorta. Am J Physiol Heart Circ Physiol 2011; 301(4): H1255-H1265.
97. Marfe G, Tafani M, Pucci B, et al. The effect of marathon on mRNA expression of anti-apoptotic and pro-apoptotic proteins and sirtuins family in male recreational long-distance runners. BMC Physiol 2010; 10: 7.
98. Fujii N, Hayashi T, Hirshman MF, et al. Exercise induces isoformspecific increase in 5' AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 2000; 273(3):1150-1155.
99. Chen ZP, Stephens TJ, Murthy S, et al. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 2003; 52(9): 2205-2212.
100. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2001; 91(3): 1017-1018.
101. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPKmediated regulation of Nampt. Dev Cell 2008; 14(5): 661-673.
102. Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458(7241): 1056-60.
103. Cantó C, Jiang LQ, Deshmukh AS, et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010; 11(3): 213-219.
104. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab 2010; 298(1): E117-E126.
105. Rutanen J, Yaluri N, Modi S, et al. SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 2010; 59(4): 829-835.
106. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305(5682): 390-392.
107. Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci USA 2007; 104(31):12861-12866.
108. Suwa M, Nakano H, Radak Z, Kumagai S. Short-term adenosine monophosphate-activated protein kinase activator 5- aminoimidazole-4-carboxamide-1-_-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle. Metabolism 2011; 60(3): 394-403.
109. Gurd BJ, Yoshida Y, Lally J, Holloway GP, Bonen A. The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J Physiol 2009; 587(Pt 8): 1817-1828.
110. Matsui T, Soya S, Okamoto M, Ichitani Y, Kawanaka K, Soya H. Brain glycogen decreases during prolonged exercise. J Physiol 2011; 589(13): 3383-3393.
111. Morton JP, MacLaren DP, Cable NT, et al. Time course and differential responses of the major heat shock protein families in human skeletal muscle following acute nondamaging treadmill exercise. J Appl Physiol 2006; 101(1): 176-182.
112. Saltin B, Gagge AP, Bergh U, Stolwijk JA. Body temperatures and sweating during exhaustive exercise. J Appl Physiol 1972; 32(5): 635-643.
113. Saltin B, Gagge AP, Stolwijk JA. Muscle temperature during submaximal exercise in man. J Appl Physiol 1968; 25(6): 679-688.
114. Liu CT, Brooks GA. Mild heat stress induces mitochondrial biogenesis in C2C12 myotubes. J Appl Physiol 2012; 112(3): 354-361.
115. Corton JM, Gillespie JG, Hardie DG. Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol 1994; 4(4): 315-324.
116. Pardo PS, Mohamed JS, Lopez MA, Boriek AM. Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response. J Biol Chem 2011; 286(4): 2559-2266.
117. Irrcher I, Hood DA. Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells. J Appl Physiol 2004; 97(6): 2207-2213.
118. Abu-Shakra SR, Cole AJ, Drachman DB. Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle. Brain Res Mol Brain Res 1993; 18(3): 216-220.
119. Clark PJ, Bhattacharya TK, Miller DS, Rhodes JS. Induction of c- Fos, Zif268, and Arc from acute bouts of voluntary wheel running in new and pre-existing adult mouse hippocampal granule neurons. Neuroscience 2011; 184: 16-27.
120. Clements KM, Wainwright PE. Swim stress increases hippocampal Zif268 expression in the spontaneously hypertensive rat. Brain Res Bull 2010; 82(5-6): 259-263.
121. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310(5746): 314-317.
122. Reiser PJ, Kline WO, Vaghy PL. Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimulation in vivo. J Appl Physiol 1997; 82(4): 1250-1255.
123. Tatchum-Talom R, Schulz R, McNeill JR, Khadour FH. Upregulation of neuronal nitric oxide synthase in skeletal muscle by swim training. Am J Physiol Heart Circ Physiol 2000; 279(4): H1757-H1766.
124. Gondim FJ, Modolo LV, Campos GE, Salgado I. Neuronal nitric oxide synthase is heterogeneously distributed in equine myofibers and highly expressed in endurance trained horses. Can J Vet Res 2005; 69(1): 46-52.
125. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS. Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 2007; 293(2): R821-R828.
126. Pattwell DM, McArdle A, Morgan JE, Patridge TA, Jackson MJ. Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells. Free Radic Biol Med 2004; 37(7): 1064-1072.
127. Hirschfield W, Moody MR, O'Brien WE, Gregg AR, Bryan RM Jr., Reid MB. Nitric oxide release and contractile properties of skeletal muscles from mice deficient in type III NOS. Am J Physiol Regul Integr Comp Physiol 2000; 278(1): R95-R100.
128. Conti V, Corbi G, Russomanno G, et al. Oxidative stress effects on endothelial cells treated with different athletes' sera. Med Sci Sports Exerc 2012; 44(1): 39-49.
129. Lavu S, Boss O, Elliott PJ, Lambert PD. Sirtuins -novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 2008; 7(10): 841-853.
130. Kelly G. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1. Altern Med Rev 2010; 15(3): 245-263.
131. Kelly GS. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Altern Med Rev 2010; 15(4): 313-328.
132. Carafa V, Nebbioso A, Altucci L. Sirtuins and disease: the road ahead. Front Pharmacol 2012; 3: 4.
133. Bao J, Sack MN. Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors. Cell Mol Life Sci 2010; 67(18): 3073-3087.
134. Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008; 283(41): 27628-27635.
135. Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2(4): 28.
136. Sakamoto K, McCarthy A, Smith D, et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 2005; 24(10): 1810-20.
137. Breen DM, Sanli T, Giacca A, Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 2008; 374(1): 117-122.
138. Hou X, Xu S, Maitland-Toolan KA, et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 2008; 283(29): 20015-20026.
139. Suchankova G, Nelson LE, Gerhart-Hines Z, et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009; 378(4): 836-841.
140. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 2003; 95(3): 960-968.
141. Suwa M, Egashira T, Nakano H, Sasaki H, Kumagai S. Metformin increases the PGC-1αprotein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol 2006; 101(6): 1685-1692.
142. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007; 6(4): 307-319.
143. Schenk S, McCurdy CE, Philp A, et al. Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J Clin Invest 2011; 121(11): 4281-4828.
144. Breen DM, Sanli T, Giacca A, Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 2008; 374(1): 117-122.
145. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444(7117): 337-342.
146. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1_. Cell 2006; 127(6): 1109-112.
147. Bordone L, Cohen D, Robinson A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007; 6(6): 759-767.
148. Kong X, Wang R, Xue Y, et al. Sirtuin 3, a new target of PGC-1α, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010; 5(7): e11707.
149. Philp A, Chen A, Lan D, et al. Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator- activated receptor-αcoactivator-1α(PGC-1α) deacetylation following endurance exercise. J Biol Chem 2011; 286(35): 30561-30570.
150. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011; 10(4): 640-647.
151. Alcendor RR, Gao S, Zhai P, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007; 100(10): 1512-1521.
152. Hsu CP, Zhai P, Yamamoto T, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122(21): 2170-2182.
153. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009; 119(9): 2758-2771.
154. Bradley RL, Jeon JY, Liu FF and Maratos-Flier E. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008; 295(3): E586-E594.
155. Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010; 298(4): E824-E831.
156. Moghadasi M, Mohebbi H, Rahmani-Nia F, Hassan-Nia S, Noroozi H, Pirooznia N. High-intensity endurance training improves adiponectin mRNA and plasma concentrations. Eur J Appl Physiol 2012; 112(4): 1207-1214.
157. Keller C, Keller P, Marshal S, Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise--effect of carbohydrate ingestion. J Physiol 2003; 550(Pt 3): 927-931.
158. Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein αtranscriptional complex. J Biol Chem. 2006; 281(52): 39915-39924.
159. Fischer-Posovszky P, Kukulus V, Tews D, et al. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 2010; 92(1): 5-15.
160. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303(5666): 2011-5.
161. Hasegawa K, Yoshikawa K. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci 2008; 28(35): 8772-8784.
162. Lanzillotta A, Sarnico I, Ingrassia R, et al. The acetylation of RelA in Lys310 dictates the NF-_B-dependent response in post-ischemic injury. Cell Death Dis 2010; 1: e96.
163. Jeong J, Juhn K, Lee H, et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 2007; 39(1): 8-13.
164. Wang P, Xu TY, Guan YF, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1- dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 2011; 69(2): 360-374.
165. Zhu HR, Wang ZY, Zhu XL, Wu XX, Li EG, Xu Y. Icariin protects against brain injury by enhancing SIRT1-dependent PGC- 1αexpression in experimental stroke. Neuropharmacology 2010; 59(1-2): 70-76.
166. Julien C, Tremblay C, Emond V, et al. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 2009; 68(1): 48-58.
167. Kim D, Nguyen MD, Dobbin MM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007; 26(13): 3169-3179.
168. Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466(7310): 1105-1109.
169. Pezet S, Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 2004; 8(5): 391-399.